FDA Renews Gastrointestinal Drugs Advisory Committee
February 24, 2026
February 24, 2026
WASHINGTON, Feb. 24 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration announced the renewal of the Gastrointestinal Drugs Advisory Committee.
As a discretionary advisory body, the committee provides expert advice to the Commissioner regarding the safety and effectiveness of marketed and investigational human drug and biologic products. These products are intended for the treatment of gastrointestinal and liver diseases. The committee also evalu . . .
As a discretionary advisory body, the committee provides expert advice to the Commissioner regarding the safety and effectiveness of marketed and investigational human drug and biologic products. These products are intended for the treatment of gastrointestinal and liver diseases. The committee also evalu . . .